Featured Research

from universities, journals, and other organizations

Blocking "Engulfment" Gives Dying Cells New Lease On Life

Date:
July 13, 2001
Source:
Cold Spring Harbor Laboratory
Summary:
Multicellular life is a balance between cell survival and cell death. The genetically programmed death of cells is a normal part of embryonic development and occurs throughout the lifetime of organisms to rid abnormal (e.g. pre-cancerous) and surplus cells from the body. Research at Cold Spring Harbor Laboratory now reveals that under special circumstances, cells programmed to die during nervous system development can be brought back from the brink of death.

Multicellular life is a balance between cell survival and cell death. The genetically programmed death of cells is a normal part of embryonic development and occurs throughout the lifetime of organisms to rid abnormal (e.g. pre-cancerous) and surplus cells from the body. Research at Cold Spring Harbor Laboratory now reveals that under special circumstances, cells programmed to die during nervous system development can be brought back from the brink of death. This finding has important implications for the treatment of neurodegenerative disease, stroke, and cancer.

The study, to be published July 12 in Nature, focused on the developing nervous system of a favored experimental organism: the soil nematode worm Caenorhabditis elegans. Cell survival and cell death during development in this animal is highly stereotyped. Among different embryos, cells in corresponding positions virtually always share the same fate. Because the worms are transparent, the fate of all cells—living, dead, or dying—can be followed relatively easily and filmed by using a video camera attached to a microscope.

Under normal circumstances, dead cells are engulfed by neighboring cells to eliminate them from the embryo. Until now, the engulfment process was viewed as an after-the-fact, disposal operation. Cold Spring Harbor Laboratory researchers Daniel Hoeppner and Michael Hengartner, together with Ralf Schnabel of the Institute for Genetics (Braunschweig, Germany), studied how the death and "burial" (engulfment) processes are coφrdinated during development of the C. elegans nervous system. They made two interesting discoveries.

First, the scientists found that when they weakened the genetically programmed signal for cells to die, most cells still died (65%) and an expected cohort of cells survived (15%). Surprisingly, however, a few cells (5%) proceeded all the way to death's door but at the very last stage before death (stage 3 of 4), they reverted to a normal appearance and survived.

Second, the researchers found that blocking engulfment in animals with a genetically weakened cell death signal increased the number of cells that escaped death to nearly 20%. Moreover, some 40% of cells slated for death in these animals survived outright, never displaying signs of death. In essence, when the engulfment machinery was disabled, cells lived that otherwise would have died. This finding indicates that the engulfment machinery actively contributes to cell killing, rather than merely eliminating dead cells.

Because many features of programmed cell death and engulfment are conserved between C. elegans and humans, the scientists suggest that modulating the activity of the engulfment machinery in humans might be an effective therapy for neurodegenerative disease, stroke, and cancer.


Story Source:

The above story is based on materials provided by Cold Spring Harbor Laboratory. Note: Materials may be edited for content and length.


Cite This Page:

Cold Spring Harbor Laboratory. "Blocking "Engulfment" Gives Dying Cells New Lease On Life." ScienceDaily. ScienceDaily, 13 July 2001. <www.sciencedaily.com/releases/2001/07/010712080935.htm>.
Cold Spring Harbor Laboratory. (2001, July 13). Blocking "Engulfment" Gives Dying Cells New Lease On Life. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2001/07/010712080935.htm
Cold Spring Harbor Laboratory. "Blocking "Engulfment" Gives Dying Cells New Lease On Life." ScienceDaily. www.sciencedaily.com/releases/2001/07/010712080935.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) — Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) — The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) — Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) — New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins